 human t-cell leukemia viru type oncogen prognost risk factor cervic vagin carcinoma seropreval human t-cell leukemia viru type htlv-i antibodi healthi femal women gynecolog malign live adult t-cell leukemia-endem area southwestern japan htlv-i infect risk factor oncogenesi prognosi seropreval cervic carcinoma patient year vagin carcinoma patient age age-match healthi control ratio observ htlv-i seropreval patient cervic carcinoma vagin carcinoma patient patient cervic carcinoma vagin carcinoma tumor recurr rate htlv-i carrier htlv-i seroneg patient result htlv-i infect oncogen prognosi patient cervic vagin carcinoma